Treace Medical Concepts, Inc. Common Stock (TMCI)
SURGICAL & MEDICAL INSTRUMENTS & APPARATUS
Treace Medical Concepts, Inc. Common Stock (TMCI) is listed on Nasdaq, where it has traded since April 23, 2021.
- Listed On
- Nasdaq
- Listed Since
- April 23, 2021
- Employees
- 450
- Market Cap
- $293M
About Treace Medical Concepts, Inc. Common Stock
Treace Medical Concepts Inc is a commercial-stage orthopaedic medical device company. It is focused on advancing the standard of care for the surgical management of bunion deformities. The company's patented Lapiplasty 3D Bunion Correction procedure is designed to reproducibly correct all planes of the bunion deformity and address the root cause of the bunion, while allowing patients to return to their active lives quickly. The company operates and manages its business as a single segment: designing, manufacturing, and marketing medical devices for surgeons, ambulatory surgery centers, and hospitals related to the surgical management of bunion and related midfoot deformities.
Institutional ownership
In 13F filings for the quarter ended June 30, 2026, 111 institutions reported holding TMCI, with 31.8 million shares worth $126.8 million in aggregate. The largest reported holder was Armistice Capital, with 6.4 million shares worth $25.3 million. Of the 5 largest holders listed below, 1 opened a new position in TMCI, 2 added shares, 1 reduced its position and 1 held its position unchanged during the quarter.
| Institution | Shares | Value | Quarter change |
|---|---|---|---|
| Armistice Capital | 6,364,000 | $25M | Unchanged |
| Bank of America | 3,305,100 | $13M | Added 2.83% |
| Gagnon Securities | 3,029,543 | $12M | Reduced 41.76% |
| Vanguard | 2,535,030 | $10M | Added 11.65% |
| Gagnon Advisors | 1,534,034 | $6M | New position |
Form 13F is a quarterly report that institutional investment managers with at least $100 million in qualifying securities file with the SEC. It lists long positions as of the last day of the quarter and is due within 45 days of quarter end, so these holdings describe that date rather than today.
Frequently asked questions
What is TMCI?
Treace Medical Concepts, Inc. Common Stock (TMCI) is listed on Nasdaq, where it has traded since April 23, 2021.
Who are the largest institutional holders of TMCI?
In 13F filings for the quarter ended June 30, 2026, the largest reported holders of TMCI were Armistice Capital, Bank of America and Gagnon Securities.
How many institutions own TMCI?
111 institutions reported a position in TMCI for the quarter ended June 30, 2026, worth $126.8 million in total.
Did institutions buy or sell TMCI last quarter?
Of the 5 largest reported holders, 1 opened a new position in TMCI, 2 added shares, 1 reduced its position and 1 held its position unchanged during the quarter. Every reported holder and its change is on the SentiSense ownership page for TMCI.
Every reported institutional holder, plus insider and congressional trades in TMCI, on SentiSense.